Deacylation and Reacylation of Neural Membrane Glycerophospholipids: A Matter of Life and Death
- 1 January 2000
- journal article
- review article
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 14 (3) , 123-136
- https://doi.org/10.1385/jmn:14:3:123
Abstract
The deacylation-reacylation cycle is an important mechanism responsible for the introduction of polyunsaturated fatty acids into neural membrane glycerophospholipids. It involves four enzymes, namely acyl-CoA synthetase, acyl-CoA hydrolase, acyl-CoA: lysophospholipid acyltransferase, and phospholipase A2. All of these enzymes have been purified and characterized from brain tissue. Under normal conditions, the stimulation of neural membrane receptors by neurotransmitters and growth factors results in the release of arachidonic acid from neural membrane glycerophospholipids. The released arachidonic acid acts as a second messenger itself. It can be further metabolized to eicosanoids, a group of second messengers involved in a variety of neurochemical functions. A lysophospholipid, the second product of reactions catalyzed by phospholipase A2, is rapidly acylated with acyl-CoA, resulting in the maintenance of the normal and essential neural membrane glycerophospholipid composition. However, under pathological situations (ischemia), the overstimulation of phospholipase A2 results in a rapid generation and accumulation of free fatty acids including arachidonic acid, eicosanoids, and lipid peroxides. This results in neural inflammation, oxidative stress, and neurodegeneration. In neural membranes, the deacylation-reacylation cycle maintains a balance between free and esterified fatty acids, resulting in low levels of arachidonic acid and lysophospholipids. This is necessary for not only normal membrane integrity and function, but also for the optimal activity of the membrane-bound enzymes, receptors, and ion channels involved in normal signal-transduction processes.Keywords
This publication has 38 references indexed in Scilit:
- Potentiation by vitamin D analogs of TNFα and ceramide-induced apoptosis in MCF-7 cells is associated with activation of cytosolic phospholipase A2Cell Death & Differentiation, 1999
- Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis: a new X linked contiguous gene deletion syndrome?Journal of Medical Genetics, 1998
- Evidence for the Involvement of Docosahexaenoic Acid in Cholinergic Stimulated Signal Transduction at the SynapseNeurochemical Research, 1997
- Arachidonic acid as a neurotoxic and neurotrophic substanceProgress in Neurobiology, 1995
- Role of lipid structure in the activation of phospholipase A2 by peroxidized phospholipidsLipids, 1993
- Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factorJournal of Biological Chemistry, 1993
- Phospholipid fatty acid remodeling in mammalian cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Polyphosphoinositides as a Probable Source of Brain Free Fatty Acids Accumulated at the Onset of IschemiaJournal of Neurochemistry, 1986
- Purification and properties of acyl-CoA: 1-acyl-sn-glycero-3-phosphocholine-O-acyltransferase from bovine brain microsomesArchives of Biochemistry and Biophysics, 1986
- Lignoceroyl‐CoASH ligase: enzyme defect in fatty acid β‐oxidation system in X‐linked childhood adrenoleukodystrophyFEBS Letters, 1986